Seeking efficiency in executive compensation benchmarking?

Unlock Efficiency in Executive Compensation Benchmarking with CompAnalyst Executive

CompAnalyst Executive

The charts on this page feature a breakdown of the total annual pay for the top executives at PASSAGE BIO INC as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. PASSAGE BIO INC income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. PASSAGE BIO INC annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Bruce Goldsmith Ph.D.
Former President and Chief Executive Officer
Total Cash $297,685 Equity $1,004,126 Other $1,329,059 Total Compensation $2,630,870
Alex Fotopoulos
Chief Technical Officer
Total Cash $640,357 Equity $981,148 Other $13,611 Total Compensation $1,635,116
William Chou M.D.
President and Chief Executive Officer
Total Cash $383,538 Equity $900,663 Other $11,887 Total Compensation $1,296,088
Simona King
Chief Financial Officer
Total Cash $616,797 Equity $960,933 Other $16,115 Total Compensation $1,593,845
Monika (Maria) Toernsen
Former Chief Commercial Officer
Total Cash $439,303 Equity $527,539 Other $659,650 Total Compensation $1,626,492
Edgar B. (Chip) Cale
General Counsel and Former Interim Chief Executive Officer
Total Cash $657,476 Equity $749,411 Other $16,882 Total Compensation $1,423,769
For its 2021 fiscal year, PASSAGE BIO INC, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Athena Contouriotis, M.D. Total Cash $215,960
Derrell Porter, M.D. Total Cash $377,712
Liam Ratcliffe, M.D., Ph.D. Total Cash $218,960
Maxine Gowen, Ph.D. Total Cash $655,489
Patrick Heron Total Cash $19,375
Sandip Kapadia Total Cash $225,960
Saqib Islam Total Cash $218,460
Tadataka Yamada, M.D. Total Cash $219,743
Tom Woiwode, Ph.D. Total Cash $220,960

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.